These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 16153572

  • 1. Macrolides and airway inflammation in children.
    Shinkai M, Rubin BK.
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW.
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [Abstract] [Full Text] [Related]

  • 3. [Types and characteristics of macrolides].
    Płusa T.
    Pol Merkur Lekarski; 2008 Nov; 25(149):403-7. PubMed ID: 19177775
    [Abstract] [Full Text] [Related]

  • 4. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS, Rubin BK.
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [Abstract] [Full Text] [Related]

  • 5. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
    Shinkai M, Henke MO, Rubin BK.
    Pharmacol Ther; 2008 Mar; 117(3):393-405. PubMed ID: 18289694
    [Abstract] [Full Text] [Related]

  • 6. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ, McSharry C, Chaudhuri R, Farrow S, Thomson NC.
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [Abstract] [Full Text] [Related]

  • 7. Macrolide therapy of chronic rhinosinusitis.
    Cervin A, Wallwork B.
    Rhinology; 2007 Dec; 45(4):259-67. PubMed ID: 18085018
    [Abstract] [Full Text] [Related]

  • 8. Macrolides in cystic fibrosis.
    McArdle JR, Talwalkar JS.
    Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
    [Abstract] [Full Text] [Related]

  • 9. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ, Tiddens HA, Verbrugh HA, Ott A.
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [Abstract] [Full Text] [Related]

  • 10. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA, Wolfs TF, Fleer A, Kimpen JL, van der Ent CK.
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [Abstract] [Full Text] [Related]

  • 11. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS, Egan M, Kazmierczak BI.
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [Abstract] [Full Text] [Related]

  • 12. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [Abstract] [Full Text] [Related]

  • 13. Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.
    Fecik RA, Nguyen PL, Venkatraman L.
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):741-7. PubMed ID: 16312149
    [Abstract] [Full Text] [Related]

  • 14. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE, Rubin BK.
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [Abstract] [Full Text] [Related]

  • 15. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K, Kastelik J, Morjaria JB.
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [Abstract] [Full Text] [Related]

  • 16. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A.
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [Abstract] [Full Text] [Related]

  • 17. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
    Bosnar M, Kragol G, Koštrun S, Vujasinović I, Bošnjak B, Bencetić Mihaljević V, Marušić Ištuk Z, Kapić S, Hrvačić B, Brajša K, Tavčar B, Jelić D, Glojnarić I, Verbanac D, Culić O, Padovan J, Alihodžić S, Eraković Haber V, Spaventi R.
    J Med Chem; 2012 Jul 12; 55(13):6111-23. PubMed ID: 22697905
    [Abstract] [Full Text] [Related]

  • 18. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
    Shimizu T, Suzaki H.
    Auris Nasus Larynx; 2016 Apr 12; 43(2):131-6. PubMed ID: 26441370
    [Abstract] [Full Text] [Related]

  • 19. [Antibiotic therapy in asthma exacerbation and in cystic fibrosis in children].
    Breborowicz A.
    Pol Merkur Lekarski; 2011 May 12; 30(179):349-51. PubMed ID: 21675140
    [Abstract] [Full Text] [Related]

  • 20. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
    Crowley S, Egan JJ.
    Expert Rev Anti Infect Ther; 2005 Dec 12; 3(6):923-30. PubMed ID: 16307505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.